Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Newamsterdam Pharma Company N.V. (NAMS)

Newamsterdam Pharma Company N.V. (NAMS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Newamsterdam Pharma Company N.V. GOOIMEER 2-35 NARRDEN P7 1411 DC NLD

www.newamsterdampharma.com Employees: 29 P: 35-206-2971

Description:

NewAmsterdam Pharma Holding B.V. is a late clinical-stage company focused on the research and development of transformative oral therapies for major cardiometabolic diseases. NewAmsterdam Pharma Holding B.V., formerly known as Frazier Lifesciences Acquisition Corporation, is based in MENLO PARK, Calif.

Key Statistics

Overview:

Market Capitalization, $K 2,362,310
Enterprise Value, $K 2,021,860
Shares Outstanding, K 92,386
Annual Sales, $ 14,090 K
Annual Net Income, $ -176,940 K
Last Quarter Sales, $ 29,110 K
Last Quarter Net Income, $ -16,650 K
EBIT, $ -182,620 K
EBITDA, $ -182,570 K
60-Month Beta 0.06
% of Insider Shareholders 19.50%
% of Institutional Shareholders 89.89%
Float, K 74,371
% Float 80.50%
Short Volume Ratio 0.40

Growth:

1-Year Return 155.88%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.18 on 11/06/24
Next Earnings Date N/A
Earnings Per Share ttm -1.31
EPS Growth vs. Prev Qtr 64.71%
EPS Growth vs. Prev Year 45.16%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

NAMS Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % 0.00%
Profit Margin % -1,255.78%
Debt/Equity 0.00
Price/Sales 171.72
Price/Cash Flow N/A
Price/Book 6.37
Book Value/Share 4.11
Interest Coverage -3.70
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar